And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

Steve Hoffman Biography and Net Worth

Insider of Tyme Technologies

Steve Hoffman co-founded TYME and is our Chairman of the board and Chief Science Officer. Steve served as our Chief Executive Officer from March 2015 to November 2020. Mr. Hoffman has over 30 years of experience in biochemistry and physics and has been the lead author on over 40 patents. For the last decade, he has focused on biopharmaceuticals for oncology, metabolic syndrome, and central nervous system disorders. Prior to working in biotech, he was involved in projects related to chemistry, aerospace, and laser optics. In addition to leading the scientific development for his own companies, he has worked with multiple Fortune 500 healthcare companies, academic institutions, and the US government.

What is Steve Hoffman's net worth?: The estimated net worth of Steve Hoffman is at least $6.25 million as of June 21st, 2022. Mr. Hoffman owns 20,100,691 shares of Tyme Technologies stock worth more than $6,245,285 as of April 16th. This net worth estimate does not reflect any other investments that Mr. Hoffman may own. Additionally, Mr. Hoffman receives a salary of $2,600,000.00 as Insider at Tyme Technologies. Learn More about Steve Hoffman's net worth.
How old is Steve Hoffman?: Mr. Hoffman is currently 59 years old. There are 5 older executives and no younger executives at Tyme Technologies. Learn More on Steve Hoffman's age.
What is Steve Hoffman's salary?: As the Insider of Tyme Technologies, Inc., Mr. Hoffman earns $2,600,000.00 per year. Learn More on Steve Hoffman's salary.
How do I contact Steve Hoffman?: The corporate mailing address for Mr. Hoffman and other Tyme Technologies executives is 17 STATE STREET 7TH FLOOR, NEW YORK NY, 10004. Tyme Technologies can also be reached via phone at (212) 461-2315 and via email at [email protected]. Learn More on Steve Hoffman's contact information.
Has Steve Hoffman been buying or selling shares of Tyme Technologies?: Steve Hoffman has not been actively trading shares of Tyme Technologies in the last ninety days. Most recently, Steve Hoffman sold 78,125 shares of the business's stock in a transaction on Tuesday, June 21st. The shares were sold at an average price of $0.26, for a transaction totalling $20,312.50. Following the completion of the sale, the director now directly owns 20,100,691 shares of the company's stock, valued at $5,226,179.66. Learn More on Steve Hoffman's trading history.
Who are Tyme Technologies' active insiders?: Tyme Technologies' insider roster includes James Biehl (Insider), David Carberry (Director), Michael Demurjian (Major Shareholder), Barbara Galaini (Insider), Steve Hoffman (Insider), and Jan Van Rornout (Insider). Learn More on Tyme Technologies' active insiders.

Steve Hoffman Insider Trading History at Tyme Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/21/2022	Sell	78,125	$0.26	$20,312.50	20,100,691
6/8/2022	Sell	78,125	$0.27	$21,093.75	20,256,941
5/25/2022	Sell	78,125	$0.24	$18,750.00	20,413,191
5/9/2022	Sell	78,125	$0.31	$24,218.75	20,569,441
4/27/2022	Sell	78,125	$0.32	$25,000.00	20,725,691
4/11/2022	Sell	78,125	$0.31	$24,218.75	20,881,941
3/28/2022	Sell	78,125	$0.34	$26,562.50
3/10/2022	Sell	78,125	$0.31	$24,218.75
2/7/2022	Sell	78,125	$0.36	$28,125.00
1/25/2022	Sell	78,125	$0.51	$39,843.75
12/16/2021	Sell	78,125	$0.72	$56,250.00
12/2/2021	Sell	78,125	$0.72	$56,250.00
11/29/2021	Sell	78,125	$0.74	$57,812.50
11/15/2021	Sell	78,125	$0.92	$71,875.00
10/26/2021	Sell	78,125	$0.97	$75,781.25
10/4/2021	Sell	78,125	$1.00	$78,125.00
8/3/2021	Sell	94,425	$1.13	$106,700.25	23,497,873
7/29/2021	Sell	156,275	$1.20	$187,530.00	23,680,223
7/20/2021	Sell	78,125	$1.05	$82,031.25	23,914,623
6/17/2021	Sell	41,250	$1.33	$54,862.50	24,033,998
6/8/2021	Sell	41,250	$1.57	$64,762.50	24,116,498
5/26/2021	Sell	41,250	$1.38	$56,925.00	24,198,998
5/11/2021	Sell	41,250	$1.20	$49,500.00	24,281,498
4/28/2021	Sell	83,500	$1.57	$131,095.00
4/13/2021	Sell	41,750	$1.51	$63,042.50	24,447,998
3/25/2021	Sell	41,750	$1.79	$74,732.50	24,531,498
3/9/2021	Sell	41,750	$1.92	$80,160.00	24,614,998
1/21/2021	Sell	56,250	$1.89	$106,312.50	25,868,998
1/5/2021	Sell	56,250	$1.36	$76,500.00	24,981,498
12/16/2020	Sell	112,500	$1.14	$128,250.00
12/3/2020	Sell	68,406	$1.09	$74,562.54	25,706,498
11/18/2020	Sell	59,442	$0.94	$55,875.48	25,812,083
11/3/2020	Sell	29,561	$0.89	$26,309.29	25,882,845
10/22/2020	Sell	37,842	$0.98	$37,085.16	25,929,946
10/7/2020	Sell	62,500	$0.99	$61,875.00	25,981,498
9/22/2020	Sell	31,250	$0.96	$30,000.00	26,043,998
8/13/2020	Sell	61,951	$1.20	$74,341.20	26,283,998
7/28/2020	Sell	51,000	$1.21	$61,710.00	26,390,449
7/16/2020	Sell	51,299	$1.26	$64,636.74	26,466,949
11/15/2019	Buy	10,000	$1.03	$10,300.00	26,492,748
6/14/2019	Buy	15,000	$1.08	$16,200.00
6/25/2018	Sell	176,780	$3.79	$669,996.20
6/18/2018	Sell	13,425	$3.75	$50,343.75
2/12/2018	Sell	17,986	$3.82	$68,706.52

Steve Hoffman Buying and Selling Activity at Tyme Technologies

Tyme Technologies Company Overview

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey.

Today's Range

Now: $0.31

$0.29

$0.32

50 Day Range

MA: $0.30

$0.24

$0.35

2 Week Range

Now: $0.31

$0.22

$1.14

Volume

2,678,186 shs

Average Volume

1,009,732 shs

Market Capitalization

$53.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

Steve Hoffman Biography and Net Worth

What is Steve Hoffman's net worth?

How old is Steve Hoffman?

What is Steve Hoffman's salary?

How do I contact Steve Hoffman?

Has Steve Hoffman been buying or selling shares of Tyme Technologies?

Who are Tyme Technologies' active insiders?